IVAC MUTANOME Phase I Clinical Trial
NCT02035956
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
BIOLOGICAL:
IVAC MUTANOME, RBL001/RBL002
Sponsor
BioNTech RNA Pharmaceuticals GmbH